Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 20:15 | 2026-08-10 | LITB | LightInTheBox Holding Co., Ltd. | He Jian | Director, Officer, 10% owner - Chief Executive Officer | Retail-Catalog & Mail-Order Houses | BUY | $0.26 | 4,254,553 | $1,092,144 | 4,254,553 | +100.0% |
| 2026-08-11 20:05 | 2026-08-10 | APTV | Aptiv PLC | CLARK KEVIN P | Director, Officer - Chair and CEO | Motor Vehicle Parts & Accessories | BUY | $48.89 | 51,190 | $2,502,684 | 651,016 | +8.5% |
| 2026-08-11 21:45 | 2026-08-11 | DINO | HF Sinclair Corp | MYERS FRANKLIN | Director, Officer - CEO | Pipe Lines (No Natural Gas) | BUY | $85.30 | 15,000 | $1,279,500 | 194,841 | +8.3% |
| 2026-08-11 21:53 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | AH Bio Fund IV, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 1,100,000 | $19,800,000 | 10,232,420 | +12.0% |
| 2026-08-11 21:31 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Chimovits Erez | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 1,940,000 | $34,920,000 | 273,333 | +100.0% |
| 2026-08-11 21:15 | 2026-08-07 | QVCG | QVC INC | GOLDENTREE ASSET MANAGEMENT LP | 10% owner | Retail-Catalog & Mail-Order Houses | BUY | $15.35 | 650,808 | $9,987,300 | 8,518,677 | +8.3% |
| 2026-08-11 21:20 | 2026-08-07 | N/A | Neuberger Asset-Based Credit Fund | Neuberger Berman Group LLC | 10% owner, Other | Other | BUY | $10.25 | 195,122 | $2,000,000 | 9,769,272 | +2.0% |
| 2026-08-11 21:27 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | ORBIMED ADVISORS LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 1,940,000 | $34,920,000 | 273,333 | +100.0% |
| 2026-08-11 21:08 | 2026-08-07 | TXO | TXO Partners, L.P. | SIMPSON BOB R | Director, 10% owner | Crude Petroleum & Natural Gas | BUY | $13.95 | 250,000 | $3,487,625 | 9,350,000 | +2.7% |
| 2026-08-11 20:49 | 2026-08-06 | N/A | West Bay BDC LLC | Qatar Investment Authority | 10% owner | Other | BUY | $17.51 | 1,541,914 | $27,000,000 | 17,668,436 | +9.6% |
| 2026-08-11 20:27 | 2026-08-07 | LILA | Liberty Latin America Ltd. | MALONE JOHN C | 10% owner, Other | Cable & Other Pay Television Services | BUY | $13.38 | 217,032 | $2,904,778 | 1,351,126 | +19.1% |
| 2026-08-11 16:25 | 2026-08-07 | N/A | Privacore VPC Asset Backed Credit Fund | BANKERS LIFE & CASUALTY CO | 10% owner | Other | BUY | $10.15 | 492,611 | $5,000,000 | 5,474,762 | +9.9% |
| 2026-08-11 00:21 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | Foresite Capital Management V, LLC | 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 140,000 | $2,520,000 | 2,008,024 | +7.5% |
| 2026-08-11 00:00 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | Tananbaum James B. | Director, 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 140,000 | $2,520,000 | 2,008,024 | +7.5% |
| 2026-08-10 23:15 | 2026-08-06 | NATR | NATURES SUNSHINE PRODUCTS INC | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 10% owner | Pharmaceutical Preparations | BUY | $16.40 | 141,389 | $2,318,907 | 1,924,486 | +7.9% |
| 2026-08-10 22:32 | 2026-08-10 | BLSM | BlossomHill Therapeutics, Inc. | Chen Bihua | Director, 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 312,500 | $5,000,000 | 3,614,034 | +9.5% |
| 2026-08-10 21:00 | 2026-08-06 | FBIN | Fortune Brands Innovations, Inc. | Singh Jesse G | Director, Officer - Chief Executive Officer | Millwood, Veneer, Plywood, & Structural Wood Members | BUY | $51.30 | 39,285 | $2,015,340 | 39,285 | +100.0% |
| 2026-08-10 20:45 | 2026-08-06 | CLVT | CLARIVATE PLC | Cornick Kenneth L. | Director | Services-Computer Processing & Data Preparation | BUY | $1.86 | 900,000 | $1,671,480 | 2,000,000 | +81.8% |
| 2026-08-10 20:12 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | venBio Global Strategic Fund IV, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 382,352 | $6,499,984 | 4,181,367 | +10.1% |
| 2026-08-10 16:57 | 2026-08-06 | VEON | VEON Ltd. | Fabela Augie K II | Director | Radiotelephone Communications | BUY | $56.00 | 20,000 | $1,120,054 | 96,000 | +26.3% |
| 2026-08-10 10:31 | 2026-07-31 | COE | 51Talk Online Education Group | Huang Jack Jiajia | Director, Officer, 10% owner - Chief Executive Officer | Services-Educational Services | BUY | $18.58 | 740,760 | $13,761,099 | 34,440,240 | +2.2% |
| 2026-08-07 20:30 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Murdoch Travis | Director, Officer - CEO and President | Pharmaceutical Preparations | BUY | $18.00 | 83,333 | $1,499,994 | 2,940,670 | +2.9% |
| 2026-08-07 20:15 | 2026-08-05 | ABTC | American Bitcoin Corp. | Mateen Justin | Director | Finance Services | BUY | $6.29 | 306,981 | $1,929,621 | 492,297 | +165.7% |
| 2026-08-08 01:47 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Redmile Group, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 600,000 | $10,200,000 | 1,182,854 | +102.9% |
| 2026-08-07 21:25 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Forbion Growth Opportunities Fund III Cooperatief U.A. | 10% owner | Pharmaceutical Preparations | BUY | $18.00 | 3,600,000 | $64,800,000 | 10,185,478 | +54.7% |
| 2026-08-07 20:31 | 2026-08-07 | BRVE | Braveheart Bio, Inc. | Viehbacher Christopher | Director | Pharmaceutical Preparations | BUY | $18.00 | 83,333 | $1,499,994 | 609,519 | +15.8% |
| 2026-08-07 19:45 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Sanofi | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 300,000 | $5,100,000 | 1,082,855 | +38.3% |
| 2026-08-07 19:53 | 2026-08-06 | SCISX | MA Specialty Credit Income Fund | MA Eagle II Holdings Fund | 10% owner | Other | BUY | $24.71 | 404,694 | $10,000,000 | 3,568,254 | +12.8% |
| 2026-08-06 23:42 | 2026-07-14 | REBN | Reborn Coffee, Inc. | Lim Jung Jae | Director, Officer - CEO and Interim CFO | Retail-Eating Places | BUY | $180,000.00 | 131,387 | $23,649,660,000 | 131,387 | +100.0% |
| 2026-08-06 21:35 | 2026-08-04 | THRY | Thryv Holdings, Inc. | PAULSON & CO. INC. | 10% owner | Services-Advertising | BUY | $2.81 | 399,548 | $1,122,370 | 8,843,383 | +4.7% |
| 2026-08-06 21:35 | 2026-08-06 | ATTO | Attovia Therapeutics, Inc. | Frazier Life Sciences XI, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $17.00 | 588,235 | $9,999,995 | 6,154,213 | +10.6% |
| 2026-08-06 20:05 | 2026-08-05 | APTV | Aptiv PLC | MEISTER PAUL M | Director | Motor Vehicle Parts & Accessories | BUY | $47.33 | 105,631 | $4,999,959 | 105,631 | +100.0% |
| 2026-08-06 10:03 | 2026-08-05 | TM | TOYOTA MOTOR CORP/ | Kon Kenta | Director, Officer - President | Motor Vehicles & Passenger Car Bodies | BUY | $18.41 | 85,000 | $1,564,850 | 148,100 | +134.7% |
| 2026-08-05 20:01 | 2026-08-03 | N/A | Privacore VPC Asset Backed Credit Fund | Corbin Capital Partners, L.P. | 10% owner | Other | BUY | $10.14 | 246,548 | $2,500,000 | 3,721,745 | +7.1% |
| 2026-08-05 23:00 | 2026-08-03 | IR | Ingersoll Rand Inc. | Satpathy Aurobind | Director | General Industrial Machinery & Equipment | BUY | $86.68 | 11,538 | $1,000,091 | 11,538 | +100.0% |
| 2026-08-05 22:21 | 2026-08-03 | XIIIU | Churchill Capital Corp XIII | Klein Michael Stuart | Director, Officer, 10% owner - See Remarks | Other | BUY | $10.00 | 350,000 | $3,500,000 | 350,000 | +100.0% |
| 2026-08-05 20:15 | 2026-08-03 | BSX | BOSTON SCIENTIFIC CORP | Mahoney Michael F | Director, Officer - Chairman, President & CEO | Surgical & Medical Instruments & Apparatus | BUY | $48.33 | 186,240 | $9,001,408 | 1,590,024 | +13.3% |
| 2026-08-05 20:18 | 2026-08-03 | APMD | Apnimed, Inc. | Morningside Venture Investments Ltd | 10% owner | Pharmaceutical Preparations | BUY | $16.00 | 312,500 | $5,000,000 | 7,152,713 | +4.6% |
| 2026-08-05 17:49 | 2026-08-04 | NFRX | 2023 ETF Series Trust | Harrison Street Real Assets Fund LLC | 10% owner | Other | BUY | $26.82 | 372,856 | $9,999,998 | 4,203,172 | +9.7% |
| 2026-08-05 13:27 | 2026-08-04 | CSGP | COSTAR GROUP, INC. | FLORANCE ANDREW C | Director, Officer - Founder and CEO | Services-Business Services, NEC | BUY | $29.89 | 83,300 | $2,489,837 | 1,806,165 | +4.8% |
| 2026-08-05 10:30 | 2026-07-28 | COE | 51Talk Online Education Group | Huang Jack Jiajia | Director, Officer, 10% owner - Chief Executive Officer | Services-Educational Services | BUY | $17.02 | 473,520 | $8,060,447 | 33,699,480 | +1.4% |
| 2026-08-04 21:04 | 2026-07-31 | CVNA | CARVANA CO. | MAROONE MICHAEL E | Director | Retail-Auto Dealers & Gasoline Stations | BUY | $61.80 | 25,000 | $1,544,983 | 168,573 | +17.4% |
| 2026-08-05 00:47 | 2026-07-31 | EWAV | East West Ave Acquisition Corp. | Space Summit Capital LLC | Other | Blank Checks | BUY | $10.00 | 1,087,000 | $10,870,000 | 1,087,000 | +100.0% |
| 2026-08-04 21:12 | 2026-07-31 | GSHD | Goosehead Insurance, Inc. | Durable Capital Partners LP | 10% owner | Insurance Agents, Brokers & Service | BUY | $61.92 | 36,256 | $2,245,142 | 2,570,260 | +1.4% |
| 2026-08-04 20:15 | 2026-07-31 | APCX | AppTech Payments Corp. | LORD ALBERT L | Director | Services-Prepackaged Software | BUY | $2,897.50 | 40,000 | $115,900,000 | 1,040,000 | +4.0% |
| 2026-08-04 15:30 | 2026-07-31 | N-A | John Hancock GA Mortgage Trust | Manufacturers Life Reinsurance Ltd | 10% owner | Other | BUY | $18.19 | 219,849 | $3,999,935 | 54,787,533 | +0.4% |
| 2026-08-04 15:19 | 2026-07-31 | N-A | John Hancock GA Mortgage Trust | Manulife (Singapore) Pte. Ltd. | 10% owner | Other | BUY | $18.19 | 109,925 | $1,999,968 | 16,291,790 | +0.7% |
| 2026-08-04 15:24 | 2026-07-31 | N-A | John Hancock GA Mortgage Trust | Manulife (International) Ltd | 10% owner | Other | BUY | $18.19 | 219,849 | $3,999,935 | 46,897,027 | +0.5% |
| 2026-08-03 21:53 | 2026-07-30 | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10% owner | Pharmaceutical Preparations | BUY | $4.93 | 329,153 | $1,624,107 | 722,419 | +83.7% |
| 2026-07-31 21:05 | 2026-07-29 | N/A | Diameter Dynamic Credit Fund | Green Joshua Michael | Director | Other | BUY | $10.04 | 124,502 | $1,250,000 | 124,502 | +100.0% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.